clinical trials

News

Acadia, Harmony record late-stage rare disease failures

Biotechs Acadia Pharma and Harmony Biosciences both suffered setbacks in phase 3 trials of drugs for rare diseases, in one case ending the programme.

News

Joy as uniQure Huntington's therapy clears pivotal trial

uniQure's gene therapy AMT-130 has cleared a trial in Huntington's, setting up filings and raising the prospect of a first treatment for the disease.

News

BMS eyes filings for myeloma 'celmod' iberdomide

Bristol Myers Squibb has said it hopes to be ready soon to file for approval of its multiple myeloma drug iberdomide after a positive phase 3 trial.

News

Roche's oral SERD comes good in 2nd-line breast cancer trial

Roche has staked a claim to use its oral SERD giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status.

News

Bayer starts pivotal Parkinson's cell therapy trial

Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway.

News

Silhouette contemplates time clock, lightbulbs of thought on sepia background

UK specialists call for more testing on psychedelics

UK psychiatrists have called for a relaxation of restrictive rules on testing psychedelics, which are holding back research and clinical use.

Acadia, Harmony record late-stage rare disease failures

Joy as uniQure Huntington's therapy clears pivotal trial

BMS eyes filings for myeloma 'celmod' iberdomide

Roche's oral SERD comes good in 2nd-line breast cancer trial

Bayer starts pivotal Parkinson's cell therapy trial

UK specialists call for more testing on psychedelics

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks